Table 2.
Variable | R2 | R2 change | F | β | t | % Unique variance | |
---|---|---|---|---|---|---|---|
Regressions assessing individual contributions of variables | |||||||
Maximum pain report (0–100 mm VAS) | |||||||
Trait anxiety regression | 0.13 | 3.82* | |||||
Step 1 | Sex | 0.16 | 1.44 | ||||
Step 2 | GI inflammation | 0.13 | 1.19 | ||||
Step 3 | Trait anxiety | 0.09 | 0.30 | 2.75* | 8.64 | ||
Somatization regression | 0.17 | 5.25* | |||||
Step 1 | Sex | 0.17 | 1.64 | ||||
Step 2 | GI inflammation | 0.04 | 0.38 | ||||
Step 3 | Somatization | 0.13 | 0.37 | 3.41* | 12.67 | ||
Number of pain episodes | |||||||
Trait anxiety regression | 0.11 | 3.09* | |||||
Step 1 | Sex | 0.17 | 1.53 | ||||
Step 2 | GI inflammation | 0.03 | 0.31 | ||||
Step 3 | Trait anxiety | 0.07 | 0.27 | 2.50* | 7.29 | ||
Somatization regression | 0.20 | 6.16* | |||||
Step 1 | Sex | 0.18 | 1.75 | ||||
Step 2 | GI inflammation | −0.06 | −0.59 | ||||
Step 3 | Somatization | 0.16 | 0.41 | 3.89* | 16.00 | ||
Regressions assessing incremental value of trait anxiety | |||||||
Maximum pain report (0–100 mm VAS) | 0.20 | 4.56* | |||||
Step 1 | Sex | 0.17 | 1.66 | ||||
GI inflammation | 0.06 | 0.56 | |||||
Step 2 | Somatization | 0.21 | 0.29 | 2.43* | 6.30 | ||
Step 3 | Trait anxiety | 0.01 | 0.17 | 1.50 | 2.40 | ||
Number of pain episodes | 0.21 | 4.86* | |||||
Step 1 | Sex | 0.18 | 1.76 | ||||
GI inflammation | −0.05 | −0.47 | |||||
Step 2 | Somatization | 0.21 | 0.36 | 3.05* | 9.86 | ||
Step 3 | Trait anxiety | 0.00 | 0.11 | 0.99 | 1.04 |
VAS: visual analog scale; GI: gastrointestinal.
R2 change is provided for trait anxiety and somatization.
p < .05.